Asif Ali - 02 Jan 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role: Chief Financial Officer
Signature: /s/ Matthew Gosling, Attorney-in-Fact for Asif Ali
Issuer symbol: PTGX
Transactions as of: 02 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2025, 18:05:16 UTC
Previous filing: 13 Sep 2024
Next filing: 17 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTGX	Common Stock	Award	$0	+31,779	+91%	$0.000000	66,739	02 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTGX	Stock Option (right to buy)	Award	$0	+38,520		$0.000000	38,520	02 Jan 2025	Common Stock	38,520	$38.98	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
F2	The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.